tailieunhanh - Báo cáo y học: "Recurrence of suicidal ideation due to treatment with antidepressants in anxiety disorder: a case report"

Tuyển tập báo cáo các nghiên cứu khoa học quốc tế ngành y học dành cho các bạn tham khảo đề tài: Recurrence of suicidal ideation due to treatment with antidepressants in anxiety disorder: a case report. | Journal of Medical Case Reports BioMed Central Case report Recurrence of suicidal ideation due to treatment with antidepressants in anxiety disorder a case report Doron Todder 1 and Bernhard T Baune2 3 Open Access Address Department of Psychiatry Ben-Gurion University Beer-Sheva Israel 2Department of Psychiatry University of Muenster Germany and 3Department of Psychiatry James Cook University Australia Email DoronTodder - dtoder@ Bernhard T Baune - bbaune@ Corresponding author Published 3 December 2007 Received 3 September 2007 -. . J Accepted 3 December 2007 Journal of Medical Case Reports 2007 1 166 doi l 752-1947-1-166 This article is available from http content 1 1 166 2007 Todder and Baune licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License http licenses by which permits unrestricted use distribution and reproduction in any medium provided the original work is properly cited. Abstract_ This report describes a patient suffering from panic disorder who developed repeated suicidal ideation specifically due to the treatment with Venlafaxine. A first suicide attempt years ago occurred while being treated with Venlafaxine. Subsequent treatment with SSRIs or other antidepressants involved no suicidal ideation. Re-commencement of Venlafaxine four years later immediately led to a second suicide attempt. This unwanted effect subsided immediately after switching to another SNRI . Duloxetine . The case report underlines the importance of onset of suicide risk in panic disorders due to specific antidepressants. Introduction Since the introduction of the first specific serotonin reuptake inhibitors SSRI Fluoxetine a concern emerged regarding the risk of developing suicide ideation as a rare side effect 1 . During 2003 Britain